SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 53 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,000 | -81.4% | 90,036 | -19.6% | 0.00% | – |
| Q2 2019 | $97,000 | -94.8% | 111,938 | -86.0% | 0.00% | – |
| Q1 2019 | $1,860,000 | +1.6% | 801,898 | +1.6% | 0.00% | – |
| Q4 2018 | $1,830,000 | -88.1% | 789,027 | -24.2% | 0.00% | -100.0% |
| Q3 2018 | $15,417,000 | +0.4% | 1,040,257 | +3.0% | 0.00% | 0.0% |
| Q2 2018 | $15,348,000 | -10.5% | 1,010,338 | +10.6% | 0.00% | 0.0% |
| Q1 2018 | $17,149,000 | +87.3% | 913,176 | +81.1% | 0.00% | – |
| Q4 2017 | $9,155,000 | +83.4% | 504,370 | +124.8% | 0.00% | – |
| Q3 2017 | $4,992,000 | – | 224,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 758,610 | $1,760,000 | 1.30% |
| Wildcat Capital Management, LLC | 295,613 | $686,000 | 0.45% |
| PFM Health Sciences, LP | 1,576,619 | $3,658,000 | 0.10% |
| Cohen Capital Management, Inc. | 108,010 | $251,000 | 0.07% |
| Partner Investment Management, L.P. | 15,283 | $35,000 | 0.04% |
| CLOUGH CAPITAL PARTNERS L P | 136,228 | $316,000 | 0.04% |
| Tower Research Capital LLC (TRC) | 12,183 | $29,000 | 0.00% |
| Assenagon Asset Management S.A. | 69,931 | $162,000 | 0.00% |
| Ballentine Partners, LLC | 16,700 | $39,000 | 0.00% |
| A.R.T. Advisors, LLC | 10,206 | $24,000 | 0.00% |